(CA)n Microsatellite polymorphism of ERBB-1 in breast cancer

European Journal of Cancer

Volumn 42, Issue 12, 2006, Pages 1698-1701

  Wełnicka Jaśkiewicz, Marzena ^a   Zaczek, Anna ^a,b   Brandt, Burkhard ^c   Bielawski, Krzysztof Piotr ^a   Jaśkiewicz, Janusz ^a   Konopa, Krzysztof ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Allelic imbalance; Breast cancer; ERBB 1; Microsatellite polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; MICROSATELLITE DNA; REPETITIVE DNA;

ALLELE; ARTICLE; BLOOD; BREAST CANCER; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENETIC POLYMORPHISM; HISTOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR CELL;

ALLELIC IMBALANCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; GENES, ERBB-1; HUMANS; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 33746712253     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.03.012     Document Type: Article

References (22)

1. Gullick W.J., Marsden J.J., Ward B., et al. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 46 (1997) 285-292
2. Gasparini G., Boracci P., Bevilacqua P., et al. Multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma. Breast Cancer Res 29 (1994) 59-71
3. Benz C.C., Brandt B.H., and Zanker K.S. Gene diagnostics provide insights into breast cancer prognosis and therapy. Gene 159 (1995) 3-7
4. Gebhardt F., Burger H., and Brandt B. Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations - links between genetics and epigenetics. Histol Histopathol 15 (2000) 929-936
5. Gebhardt F., Zanker K.S., and Brandt B. Modulation of epidermal growth factor receptor gene transcription by polymorphic dinucleotide repeat in intron 1. J Biol Chem 274 (1999) 13176-13180
6. Gebhardt F., Rotger A., Zanker K.S., and Brandt B. Regulation of epidermal growth factor receptor in human carcinoma cell lines by structurally different 5'-transcripts. Proc Amer Assoc Cancer Res 38 (1997) 184
7. Tidow N., Boecker A., Schmidt H., et al. Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res 63 (2003) 1172-1178
8. Chi D.D., Hing A.V., Helms C., Steinbrueck T., Mishra S.K., and Donis-Keller H. Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2). Hum Mol Genet 1 (1992) 135
9. Buerger H., Gebhardt F., Schmidt H., et al. Length and loss of heterozygosity of an intron 1 polymorphic sequence of EGFR is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res 60 (2000) 854-857
10. Liu W., Innocenti F., Chen P., et al. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 9 (2003) 1009-1012
11. Canzian F., Salovaara R., and Hemmiki A.I. Semiautomated assesment of loss of heterozygosity and replication error in tumours. Cancer Res 56 (1996) 3331-3337
12. Holbro T., Civenni G., and Hynes N.E. The ErbB receptors and their role in cancer progression. Exp Cell Res 284 (2003) 99-110
13. Gullick W.J., and Srinivasan R. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res Treat 52 (1998) 43-53
14. van de Vijver M.J. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2). Eur J Cancer 37 suppl 1 (2001) 11-17
15. Zaczek A., Brandt B., and Bielawski K.P. The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histol Histopathol 20 (2005) 1005-1015
16. Ross J.S., Fletcher J.A., Bloom, et al. Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics 3 (2004) 379-398
17. Brown N.M., Wang J., Cotreno M.S., et al. Prepubertal genistein treatment modulates TGF-α, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol 144 (1998) 149-165
18. Brandt B., Hermann S., Straif K., Tidow N., Buerger H., and Chang-Claude J. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene. Cancer Res 64 (2004) 7-12
19. Bielawski K.P., Klos P., Welnicka-Jaskiewicz M., et al. An epidermal growth factor receptor intron 1 polymorphism in healthy women in Poland. Int J Biol Markers 20 (2005) 184-188
20. Fukuoka M., Yano S., Giaccone G., et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer. J Clin Oncol 21 (2003) 2237-2246
21. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
22. Paez G., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: correlations with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500